Cancer stemness was suppressed by dinaciclib or THZ531 treatment (Fig. 7), or knockdown of CCNK (Fig. 3); hence, CDK12 inhibitors are potential chemotherapeutic agents against colon cancer. This evidence concerns the gene CCNK and colonic neoplasm.